Has the incidence of multiple myeloma in old age been underestimated?-Reference-Cited by-同舟云学术

Has the incidence of multiple myeloma in old age been underestimated?

Published:2009-04-24 Issue:5 Volume:47 Page:333-337
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Wisløff F.,Andersen P.,Andersson T. R.,Brandt E.,Eika C.,Fjaestad K.,Ly B.,Løvåsen K.,Strøm B. Riis,Tjønnfjord G. E.

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1991.tb01856.x/fullpdf

Reference30 articles.

1. Melphalan/prednisone versus drug combinations for plasma cell myeloma;Bergsagel;Eur J Haematol,1989

2. Prognostic factors and classification in multiple myeloma;Miguel;Br J Cancer,1989

3. Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus melphalan and prednisone in multiple myeloma;Abramson;Cancer Treat Rep,1982

4. Aggressive combination chemotherapy in multiple myeloma. A multi-center trial;Palva;Scand J Haematol

5. Intensive treatment of multiple myeloma and criteria for complete remission;Gore;Lancet,1989

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple myeloma as a cause of primary graft dysfunction after kidney transplantation;Vnitřní lékařství;2024-06-20

2. Présentation épidémiologique, clinique, biologique et pronostique du myélome multiple à Casablanca (Maroc);Journal Africain du Cancer / African Journal of Cancer;2014-02-15

3. Patterns of Multiple Myeloma During the Past 5 Decades: Stable Incidence Rates for All Age Groups in the Population but Rapidly Changing Age Distribution in the Clinic;Mayo Clinic Proceedings;2010-03

4. The Role of Allogeneic Transplantation for Multiple Myeloma in Older Adults;Allogeneic Stem Cell Transplantation;2009-11-27

5. Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I - A randomized study;European Journal of Haematology;2009-04-24